- Guidelines Help Keep Student Athletes And Musicians From Getting Sick As Temps Soar
- FDA bans some Mexican cilantro after feces found in fields
- Flea Population Exploding Due To Recent Rains
- Snake Bite Deaths Rare
- New FDA Approved Injectable Dissolves Chin Fat
- Abbott: Texas Won't Legalize Medicinal Or Recreational Pot
- Rep. Spitzer Responds To Criticism Over Abstinence Education
- Texas Army Veteran Supports Medical Marijuana Legislation
- Justices Sharply Divided Over Health Care Law Subsidies
- Listeria Found In Blue Bell Plant In 2013
- Vaccinations Don't Stop After High School
- Kyle's Youth Ban On E-Cigs Proposed As State Law
- Miller Defends Deep Fryers In Agriculture Address
- Future Of ACA Subsidies In Texas Unclear After Rulings
- Women's Groups Blast Supreme Court Ruling On Contraception
- Austin Regional Clinic Strengthens Vaccination Policy
- Travis Co. Hit Hardest in Texas Cyclospora Outbreak
- 2 Cases of Chikungunya Reported In Central Texas
- Food For Families Food Drive kicks off June 15!
- PTSD treatment Bravemind set to deploy in Texas
- Austin Man Receives World's First Ever Skull, Scalp Transplant
- Woman Loses Eyesight From Cat Lick
- Man Who Caught Listeria-Related Meningitis Sues Blue Bell
- Blue Bell Closing All 3 Creameries For Training, Cleaning
- Unusual Ice Cream Recalls Raise Questions About Cause
- CDC: 10 Listeria Illnesses Now Linked To Blue Bell Foods
- Blue Bell Suspends Operations At Oklahoma Production Plant
- 8 Dogs, 6 People Evaluated After Rabies Exposure
- Mother Fights For Food Allergy Bill After Son's Death
- Officials Search For Boy Who Had Possible Rabies Exposure At Zilker Park
- Local Pet Expert Says Food Affects Behavior, Health
- Rain Puts Mosquitoes In The Forecast
- Unlocking The Secrets Of Your DNA
- Early Exposure To Peanuts Helps Prevent Allergies In Kids
- Texas Has High Stakes In Lawsuit Over Health Law
- Measles Outbreak Highlights Vaccine Debate
- About 1 Million Texans Have Enrolled In Federal Health Plans
- Uninsured Texans Prepare To Pay The Price This Tax Season
- APD Concerned Over Spike In Traffic Fatalities
- Some Toddlers May Not Show Flu Symptoms
- Mother: Aid-In-Dying Bill Carries Brittany Maynard's Legacy
- Conjoined Twins Set For Separation In Houston
- Health Officials: Flu Vaccine Less Effective But Recommended
- Mom Loses Daughter To Flu: 'I Just Screamed And Fell To The Floor'
- Problem Of Placing People With Special Needs Increasing
- US Moves Toward Dropping Lifetime Ban On Gay Blood Donations
- New Central Texas Flu Warning
- Texas Death Among 5 Reported In Listeria Outbreak
- Flu Season In Full Swing At Leander ISD School
- CDC Warns Current Flu Vaccine May Not Be As Effective
Medical Breakthrough: Austin Brain Cancer Trial
The Austin Brain Tumor Center at Texas Oncology is leading the charge on a medical breakthrough. It's the first in the U.S. to test a drug targeting the most common and aggressive type of brain tumor.
"I just really couldn't move at all," said Zach.
Anne Tritschler couldn't believe what was happening to her husband.
"I came home from the gym and I found him lying on the kitchen floor," said Tritschler. "The gibberish that came out just freaked me out more than anything."
"We both thought that I had had a stroke," said Zach.
Zach doesn't want to use his last name.
A battery of tests led to a shocking diagnosis.
"They did an MRI and CT scan and that's when they found out through the CT that he had a brain tumor," said Tritschler.
"The type of brain tumor Glioblastoma that contains this type of tumor is clearly deadly," said Neuro-oncologist Morris D. Groves.
Groves is a physician with Texas Oncology and the Director of the Austin Brain Tumor Center. Dr. Groves also says Zach has a rare abnormality in his tumor.
"I was originally told I would live maybe five years," said Zach.
Understanding this abnormality is the focus of Dr. Groves' new, groundbreaking clinical trial.
"The breakthrough is the approach that targets the specific abnormality of the disease which is part of what makes it a tumor," said Groves.
He's testing the new drug from Novartis currently referred to as BGJ398 which targets the protein generated by this mutation.
"It works in the petri dish, it works in the animals," said Dr. Groves. "The question is will it work in people that's the only thing that matters."
Thirty-four patients across the world will be treated in the study. If it works, Zach could live another five years.
"It's awesome that Zach can be a part of this and hopefully it can help him," said Tritschler.
"This may be a part of a cure," said Dr. Groves.
The clinical trial started about three months ago. If you think you would qualify for the trial and would like to get tested, contact the Austin Brain Tumor Center at Texas Oncology.
-- Deeda Payton, KEYE TV News